BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: In both colorectal and anaplastic thyroid cancer, the presence of mutations in the BRAF gene, particularly the V600E mutation, has been shown to significantly worsen prognosis and therapeutic outcomes [8,9,10].